Palliative vs Standard Care for Parkinson Disease

JAMA Neurology

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, FEBRUARY 10, 2020

Media advisory: The full study and editorial are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2019.4992?guestAccessKey=c0b2de5e-dbd6-454f-8d75-a33e99f08e35&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=021020

 

What The Study Did: This randomized clinical trial that included 210 patients with Parkinson disease and related disorders and 175 caregivers examined whether outpatient palliative care was associated with better patient or caregiver outcomes compared with standard care.

Authors: Benzi M. Kluger, M.D., of the University of Rochester Medical Center in Rochester, New York, is the corresponding author.

 

(doi:10.1001/jamaneurol.2019.4992)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.